封面
市場調查報告書
商品編碼
1429274

全球體積描記器市場:現況分析與預測(2023-2030)

Plethysmograph Market: Current Analysis and Forecast (2023-2030)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

體積描記器是一種用於測量器官內或全身體積變化的醫療設備。 在呼吸生理學中,它經常被用來測量肺部空氣量的變化。 該設備有助於診斷呼吸系統疾病並評估肺功能。 其他幾個因素也在推動全球體積描記術的發展,包括人口老化的加劇和不健康的生活方式。 例如,根據BMC Public Health 的數據,2023 年7 月不健康生活方式的盛行率為:飲食為86.4%,飲酒為14.5%,菸草為6.0%,體力活動為72.2%,螢幕時間為42.3%,睡眠時間為63.9% 。

由於全球菸酒流行率不斷上升,體積描記器市場預計將以 4.5% 左右的速度穩定成長。 根據 2021 年全國藥物使用與健康調查 (NSDUH),2020 年有 2,950 萬名 12 歲及以上的人患有酒精使用障礙 (AUD)。 在預測期內,有幾個因素正在推動市場,包括呼吸道疾病患病率上升、對喉癌的認識不斷提高、吸煙人口增加、酗酒文化日益盛行以及醫療保健領域投資增加。我們正在促進增長。 除此之外,透過體積描記器提高治療效率可以加快治療過程並提高精確度,這也穩步推動了體積描記器市場的發展。

依產品類型分為軀幹體積描記器、四肢體積描記器等。 由於能夠有效偵測手臂和腿部的阻塞情況,四肢體積描記器將在 2022 年佔據全球體積描記器市場的最大份額。 如果它檢測到脈搏率存在差異並且手臂和腿之間的脈搏率降低,則可能存在阻塞。 由於老年人口的增加以及吸煙、酗酒等不健康生活習慣的日益普遍,該行業正在主導市場。 因此,四肢體積描記器細分市場將在 2022 年佔據主要市場份額。

根據最終用途,市場分為醫院、診所和其他。 到 2022 年,診所將佔據市場的主要份額。 診所是初級衛生保健機構,患者在這裡接受即時診斷、治療和持續護理。 我們透過提供最先進的醫療設施、專業知識和多學科的患者護理方法,在患者管理中發揮著至關重要的作用。 研究合作和收購的增加正在推動該領域的成長。 因此,診所類別在預測期內預計將出現更高的複合年增長率。

為了更了解體積描記器的市場介紹,市場包括北美(美國、加拿大、北美其他地區)、歐洲(德國、英國、法國、西班牙、義大利、歐洲其他地區)、亞太地區(中國、日本、印度、亞太地區其他地區)及世界其他地區。 在目前的 2022 年情境中,由於煙霧污染加劇、酒精消費增加以及開發有效體積描記器的投資增加,北美將主導市場。 例如,根據國家藥物濫用統計中心的數據,在約翰霍普金斯大學-馬裡蘭大學巴爾的摩分校的一項調查中,60.1% 的參與者表示,自2020 年3 月1 日以來,他們增加了飲酒量。 政府機構已啟動心臟病意識計劃,為患者提供有效的治療。 因此,按地區劃分,北美將在 2022 年佔據較大市場份額。

市場上營運的主要公司包括 ACI Medical, LLC、COSMED srl、D. E. Hokanson Inc.、Geratherm Medical AG、medical Equipment europe GmbH、Medizinische Messtechnik GmbH、MGC Diagnostics Corporation、Morgan Scientific、PulmOne Advanced 。

目錄

第一章市場介紹

  • 市場定義
  • 主要目標
  • 利害關係人
  • 限制

第二章研究方法或前提

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對體積描記器市場的影響

第 6 章體積描記器市場收入,2020-2030

第 7 章市場洞察:依產品類型

  • 軀幹體積描記器
  • 四肢體積描記器
  • 其他

第 8 章市場洞察:最終用戶

  • 醫院
  • 診所
  • 其他

第 9 章市場洞察:按地區

  • 北美
    • 美國
    • 加拿大
    • 北美其他地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 其他領域

第 10 章體積描記器市場動態

  • 市場驅動因素
  • 市場挑戰
  • 影響分析

第 11 章體積描記器的市場機會

第十二章體積描記器市場趨勢

第十三章需求方與供給方分析

  • 需求方分析
  • 供給面分析

第14章價值鏈分析

第15章競爭場景

  • 競爭狀況
    • 波特五力分析

第十六章公司簡介

  • ACI Medical, LLC
  • COSMED srl
  • D. E. Hokanson Inc.
  • Geratherm Medical AG
  • medical equipment europe GmbH
  • Medizinische Messtechnik GmbH
  • MGC Diagnostics Corporation
  • Morgan Scientific
  • PulmOne Advanced Medical Devices
  • SCHILLER AG

第十七章免責聲明

簡介目錄
Product Code: UMHE212568

A plethysmograph is a medical device used to measure changes in volume within an organ or a whole body part. It's often used in respiratory physiology to measure changes in air volume in the lungs. This device can help diagnose respiratory conditions and assess lung function. Several other factors, such as the rising geriatric population, and unhealthy lifestyles are leading drivers of plethysmographs globally. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration.

The Plethysmograph Market is expected to grow at a steady rate of around 4.5% owing to the increased prevalence of alcohol and tobacco globally. According to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had Alcohol Use Disorder (AUD) in the year 2020. Several factors, including a rising prevalence of respiratory disorders, increasing awareness regarding throat cancer, increasing smoking population, rising alcoholism culture, and increased investments in healthcare departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with plethysmograph has resulted in faster treatment procedures and better accuracy which is also driving this market of plethysmograph at a steady rate.

Based on product type, the market is segmented into body plethysmograph, limbs plethysmograph, and others. The limb plethysmograph segment held the maximum share in the global market of plethysmographs in 2022 owing to its efficiency in detecting blockage in arms and legs. It detects differences between the pulses and if there is a decrease in the pulse between the arm and leg, it may indicate a blockage. This segment dominated the market because of the increasing geriatric population, and increased prevalence of ill lifestyles including smoking, alcoholism, and unhealthy lifestyles among people. Thus, the limb plethysmograph segment held a significant share of the market in 2022.

Based on end use, the market is segmented into hospitals, clinics, and others. The clinics held a significant share of the market in 2022. Clinics serve as primary healthcare institutions where patients receive an immediate diagnosis, treatment, and ongoing care. They play a pivotal role in the management of patients by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. Rising collaborations and acquisitions are boosting this segment's growth. Hence, the clinics category is expected to witness higher CAGR during the forecast period.

For a better understanding of the market adoption of plethysmograph, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective plethysmograph. For example, according to the National Center for Drug Abuse Statistics, in a Johns Hopkins-University of Maryland-Baltimore survey, 60.1% of participants reported drinking more alcohol after March 1, 2020. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include ACI Medical, LLC; COSMED srl; D. E. Hokanson Inc.; Geratherm Medical AG; medical equipment europe GmbH; Medizinische Messtechnik GmbH; MGC Diagnostics Corporation; Morgan Scientific; PulmOne Advanced Medical Devices; SCHILLER AG.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Plethysmograph Market
  • 2.2. Research Methodology of the Plethysmograph Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PLETHYSMOGRAPH MARKET

6 PLETHYSMOGRAPH MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Body Plethysmograph
  • 7.2. Limbs Plethysmograph
  • 7.3. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 PLETHYSMOGRAPH MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 PLETHYSMOGRAPH MARKET OPPORTUNITIES

12 PLETHYSMOGRAPH MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. ACI Medical, LLC
  • 16.2. COSMED srl
  • 16.3. D. E. Hokanson Inc.
  • 16.4. Geratherm Medical AG
  • 16.5. medical equipment europe GmbH
  • 16.6. Medizinische Messtechnik GmbH
  • 16.7. MGC Diagnostics Corporation
  • 16.8. Morgan Scientific
  • 16.9. PulmOne Advanced Medical Devices
  • 16.10. SCHILLER AG

17 DISCLAIMER